The BRIDGE Rehabilitation Trial

NACompletedINTERVENTIONAL
Enrollment

381

Participants

Timeline

Start Date

August 15, 2017

Primary Completion Date

August 30, 2019

Study Completion Date

August 30, 2019

Conditions
Musculoskeletal Disease
Interventions
BEHAVIORAL

Current rehabilitation

The control group will receive the rehabilitation currently offered at each of the participating centers.

BEHAVIORAL

The BRIDGE program

The experimental group will additionally receive the BRIDGE program, which comprises motivational interviewing, structured goal-setting, tailored follow-up, plans for self-management, and individualised written feedback that participants can use to monitor their progress and share with important care givers.

Trial Locations (8)

2609

Lillehammer Rheumatism Hospital, Lillehammer

3370

Vikersund Rehabilitation Centre, Vikersund

4838

Sørlandet Hospital, Arendal

5528

Haugesund Rheumatism Hospital, Haugesund

Rehabilitering Vest, Haugesund

6210

Muritunet Rehabilitation Centre, Valldal

7530

Meråker rehabilitation centre, Meråker

8215

Valnesfjord Rehabilitation Centre, Valnesfjord

All Listed Sponsors
collaborator

Sørlandet Hospital

UNKNOWN

collaborator

Vikersund Rehabilitation Centre

UNKNOWN

collaborator

Muritunet Rehabilitation Centre

UNKNOWN

collaborator

Valnesfjord Rehabilitation Centre

UNKNOWN

collaborator

Meråker Rehabilitation Centre

UNKNOWN

collaborator

Rehab Vest Rehabilitation Centre

UNKNOWN

collaborator

Lillehammer Rheumatism Hospital

UNKNOWN

collaborator

Haugesund Rheumatism Hospital

OTHER

lead

National Resource Center for Rehabilitation in Rheumatology

OTHER

NCT03102814 - The BRIDGE Rehabilitation Trial | Biotech Hunter | Biotech Hunter